Intrinsiqs

Is Galectin Therapeutics Inc. overvalued?

Galectin Therapeutics Inc. (GALT) — key valuation metrics and fundamentals.

No verdict
Price
$4.21
Fair value
Current P/E
Normal P/E
Market cap
$293.7M
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares GALT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 30 Jun 2026.